July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
A rapid technique to quantify retinal oxidative stress and the protection provided by novel nitroxide-based antioxidant / anti-inflammatory compounds
Author Affiliations & Notes
  • Nigel L Barnett
    Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland, Australia
    Queensland Eye Institute , South Brisbane, Queensland, Australia
  • Steven E Bottle
    Queensland University of Technology, Brisbane, Queensland, Australia
  • Jason Tong
    Queensland Eye Institute , South Brisbane, Queensland, Australia
  • Komba Thomas
    Queensland University of Technology, Brisbane, Queensland, Australia
  • Cassie L Rayner
    Queensland Eye Institute , South Brisbane, Queensland, Australia
  • Footnotes
    Commercial Relationships   Nigel Barnett, None; Steven Bottle, None; Jason Tong, None; Komba Thomas, None; Cassie Rayner, None
  • Footnotes
    Support  Queensland Eye Institute Foundation
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 5740. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nigel L Barnett, Steven E Bottle, Jason Tong, Komba Thomas, Cassie L Rayner; A rapid technique to quantify retinal oxidative stress and the protection provided by novel nitroxide-based antioxidant / anti-inflammatory compounds. Invest. Ophthalmol. Vis. Sci. 2019;60(9):5740.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To develop a rapid screening technique to evaluate the capacity of novel nitroxide-based antioxidant compounds to reduce oxidative stress in cultured retinal cells, and to analyse the neuroprotection offered by a candidate compound in an in vivo model of retinal injury.

Methods : Cultured 661W mouse photoreceptor cells were incubated (45 min) with a novel mitochondrially-targeted fluorescent probe (methyl ester tetraethylrhodamine nitroxide, ME-TRN) that is reversibly responsive to cellular redox status. Oxidative stress was induced with antimycin (AMC, 1 µM) following incubation (30 min) with a nitroxide (5,6-dicarboxy-1,1,3,3-tetraethylisoindolin-2-yloxyl, DCTEIO; 2KT109A or 1KT141D) or lutein antioxidant. ME-TRN fluorescence was quantified by flow cytometry. The effects of DCTEIO were then assessed in vivo. Unilateral retinal ischemia-reperfusion (I/R) was induced in anaesthetized rats by increasing intraocular pressure (110mmHg for 1hr). DCTEIO (20 mg/kg i.p.) was administered 1 hour prior and 1 hour after I/R. An additional intravitreal injection (2µl, final conc. 100 µM) was given 30 mins into the reperfusion phase. Animals recovered for 8 days prior to assessment of retinal function by scotopic flash electroretinography (ERG).

Results : Untreated 661W cells converted the probe from a non-fluorescent (oxidized) state to a fluorescent (reduced) state. Oxidative stress decreased mean fluorescence intensity by 50%. Antioxidant data were normalized to the maximal effect of AMC and expressed as the % amelioration of the AMC-induced change in mean fluorescence. Lutein (10 µM) significantly blunted the effects of AMC by 82±23%, p=0.0002, n=8, ANOVA; DCTEIO (nitroxide antioxidant, 500 µM) by 62±13%, p=0.0002, n=5; 2KT109A (indomethacin-nitroxide hybrid, 10 µM) by 97±12%, p=0.0003, n=5, and 1KT141D (aspirin-nitroxide hybrid, 100 µM) by 92±10%, p=0.0004, n=5. A significant reduction in ERG a-wave amplitude was induced by ischemia-reperfusion, which was ameliorated by DCTEIO (I/R 265±48 µV, I/R+DCTEIO 451±43 µV, p=0.0011, n=6).

Conclusions : Flow cytometry with a reversible fluorescent probe for oxidative stress is an effective tool to assess antioxidant compounds in retinal cells. Novel nitroxide antioxidant compounds significantly ameliorated the effects of oxidative stress on 661W cells and may provide an effective neuroprotective strategy in vivo.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×